Company · CIK 1817229
Vor Biopharma Inc.
| CIK | 1817229 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Business address | MA |
| Listed | VOR (Nasdaq) |
| First annual or quarterly report | 2021-03-25 |
Offerings
9 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298767 | 2026-09-04 | 2026-09-04 | 1 | |
| 333-295346 | 2026-04-27 | 2026-05-06 | 2 | |
| 333-293052 | 2026-01-29 | 2026-02-04 | 2 | |
| 333-285969 | 2025-03-20 | 2025-11-12 | 5 | |
| 333-290490 | 2025-09-24 | 2025-09-24 | 1 | |
| 333-284380 | 2025-01-21 | 2025-01-29 | 2 | |
| 333-263541 | 2022-03-14 | 2022-12-23 | 4 | |
| 333-268798 | 2022-12-14 | 2022-12-20 | 2 | |
| 333-252175 | 2021-01-15 | 2021-02-08 | 5 |
Filings
25| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-09-04 | S-3ASRShelf registered | 333-298767 | 0001193125-26-383721 |
| 2026-05-06 | EFFECTDeclared effective | 333-295346 | 9999999995-26-001527 |
| 2026-04-27 | S-3Shelf registered | 333-295346 | 0001193125-26-182106 |
| 2026-02-04 | EFFECTDeclared effective | 333-293052 | 9999999995-26-000446 |
| 2026-01-29 | S-3Shelf registered | 333-293052 | 0001193125-26-029364 |
| 2025-11-12 | 424B5Shelf takedown | 333-285969 | 0001193125-25-275659 |
| 2025-11-10 | 424B5Shelf takedown | 333-285969 | 0001193125-25-274350 |
| 2025-09-24 | S-3Shelf registered | 333-290490 | 0001193125-25-215602 |
| 2025-08-27 | 424B5Shelf takedown | 333-285969 | 0001193125-25-189133 |
| 2025-03-31 | EFFECTDeclared effective | 333-285969 | 9999999995-25-000902 |
| 2025-03-20 | S-3Shelf registered | 333-285969 | 0001193125-25-059313 |
| 2025-01-29 | EFFECTDeclared effective | 333-284380 | 9999999995-25-000235 |
| 2025-01-21 | S-3Shelf registered | 333-284380 | 0001193125-25-009566 |
| 2022-12-23 | 424B5Shelf takedown | 333-263541 | 0001193125-22-311769 |
| 2022-12-20 | EFFECTDeclared effective | 333-268798 | 9999999995-22-003593 |
| 2022-12-14 | S-3Shelf registered | 333-268798 | 0001193125-22-304916 |
| 2022-12-08 | 424B5Shelf takedown | 333-263541 | 0001193125-22-301126 |
| 2022-03-18 | EFFECTDeclared effective | 333-263541 | 9999999995-22-000675 |
| 2022-03-14 | S-3Shelf registered | 333-263541 | 0001193125-22-074760 |
| 2021-02-08 | 424B4Final prospectus | 333-252175 | 0001193125-21-031436 |
| 2021-02-04 | EFFECTDeclared effective | 333-252175 | 9999999995-21-000446 |
| 2021-02-03 | S-1/AAmendment | 333-252175 | 0001193125-21-026728 |
| 2021-02-01 | S-1/AAmendment | 333-252175 | 0001193125-21-023537 |
| 2021-01-15 | S-1Registration filed | 333-252175 | 0001193125-21-010219 |
| 2020-11-06 | DRSDraft made public | 377-03759 | 0000950123-20-011016 |